Skip to content

PROLOR Biotech, Inc.

Delisted

CIK 1268659fmd_0VEY9K6KX6YWK50Z2KAG5H2Z3KManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2006 to Jun 30, 2013, 17 periods

Latest annual · FY2012

Millions
Total revenues
0
Operating income
(18)
Net income
(18)
Free cash flow
(17)

Latest quarter · Q2 FY2013

Millions
Total revenues
0
Operating income
(10)
Net income
(10)
Free cash flow
(6)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2009 to FY2012
n/m
Revenue, 5 yearsFY2007 to FY2012
n/m
Net income, 5 yearsFY2007 to FY2012
n/m

PROLOR Biotech, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2012FY2011ChangeSource
Revenue$0$010-K 2013-03-15 · proof
Operating income-$18.4 million-$14.8 million10-K 2013-03-15 · proof
Net income-$18.3 million-$15.1 million10-K 2013-03-15 · proof
Cash from operating activities-$16.4 million-$12 million10-K 2013-03-15 · proof
Free cash flow-$16.9 million-$12.7 million10-K 2013-03-15 · proof
Total assets$35.9 million$15 million+139.1%10-K 2013-03-15 · proof
Total liabilities$2.7 million$2.5 million+8.5%10-K 2013-03-15 · proof
Cash and cash equivalents$23.8 million$13.3 million+79.8%10-K 2013-03-15 · proof
What was PROLOR Biotech, Inc.'s revenue in fiscal 2012?
PROLOR Biotech, Inc. reported revenue of $0 for fiscal 2012 (the year ended Dec 31, 2012), against $0 the year before. Source: the 10-K filed with the SEC on Mar 15, 2013. SEC
What was PROLOR Biotech, Inc.'s operating income in fiscal 2012?
PROLOR Biotech, Inc. reported operating income of -$18.4 million for fiscal 2012 (the year ended Dec 31, 2012), against -$14.8 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2013. SEC
What was PROLOR Biotech, Inc.'s net income in fiscal 2012?
PROLOR Biotech, Inc. reported net income of -$18.3 million for fiscal 2012 (the year ended Dec 31, 2012), against -$15.1 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2013. SEC
What was PROLOR Biotech, Inc.'s cash from operating activities in fiscal 2012?
PROLOR Biotech, Inc. reported cash from operating activities of -$16.4 million for fiscal 2012 (the year ended Dec 31, 2012), against -$12 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2013. SEC
What was PROLOR Biotech, Inc.'s free cash flow in fiscal 2012?
PROLOR Biotech, Inc. reported free cash flow of -$16.9 million for fiscal 2012 (the year ended Dec 31, 2012), against -$12.7 million the year before. Source: the 10-K filed with the SEC on Mar 15, 2013. SEC
What are PROLOR Biotech, Inc.'s total assets?
As of Dec 31, 2012, PROLOR Biotech, Inc. reported total assets of $35.9 million, against $15 million a year earlier (+139.1%). Source: the 10-K filed with the SEC on Mar 15, 2013. SEC
What are PROLOR Biotech, Inc.'s total liabilities?
As of Dec 31, 2012, PROLOR Biotech, Inc. reported total liabilities of $2.7 million, against $2.5 million a year earlier (+8.5%). Source: the 10-K filed with the SEC on Mar 15, 2013. SEC
What are PROLOR Biotech, Inc.'s cash and cash equivalents?
As of Dec 31, 2012, PROLOR Biotech, Inc. reported cash and cash equivalents of $23.8 million, against $13.3 million a year earlier (+79.8%). Source: the 10-K filed with the SEC on Mar 15, 2013. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1268659&period_type=annual&limit=5"

Information only, not investment advice.